CABERGOLINE (Apotex Corp.)


Welcome to the PulseAid listing for the CABERGOLINE drug offered from Apotex Corp.. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotex Corp.
NON-PROPRIETARY NAME: CABERGOLINE
SUBSTANCE NAME: CABERGOLINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Ergolines [Chemical/Ingredient],Ergot Derivative [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-03-08
END MARKETING DATE: 0000-00-00


CABERGOLINE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCABERGOLINE from Apotex Corp.
LABELER NAME: Apotex Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2013-03-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60505-2597_b961fb84-055a-a3bd-56a6-66a6abdcd885
PRODUCT NDC: 60505-2597
APPLICATION NUMBER: ANDA201503

Other CABERGOLINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.CABERGOLINE
Avera McKennan HospitalCabergoline
Greenstone LLCCabergoline
Mylan Pharmaceuticals Inc.Cabergoline
Par Pharmaceutical, Inc.Cabergoline
Teva Pharmaceuticals USA IncCabergoline